Uterine cancer is a deadly cancer that can develop in women. While development of this and other related cancers is rare, many women found themselves at an increased risk after undergoing a procedure using a power morcellator. Power morcellators are used to extract tissue and fibroids during a hysterectomy or a myomectomy by mincing up tissue for removal through a small incision in the abdomen. The morcellator works using a drill-like end that rotates and breaks masses of tissues in smaller pieces and then vacuuming them out. Unfortunately, many times cancerous tissues were either left behind or spread.
According to Williams Kherkher, while these devices could be used to remove noncancerous tissue, they were dangerous if a women had undetected malignant tissue for these reasons. A power morcellator could cause deadly cancers such as metastatic leiomyosarcoma, uterine cancer, uterine sarcoma, and endometrial stromal sarcoma. In 2014, the U.S. Food and Drug Administration (FDA) issued an official warning against morcellators which was soon followed by a recall of the devices. After these dangers came into the public eye, lawsuits against negligent and responsible parties were filed.
Although these dangers were eventually made public, it was too late for many victims who had already developed deadly cancers or other harmful symptoms. In fact, 1 in every 350 procedures involving a power morcellator led to the development of one of these cancers.